Olema Pharmaceuticals Statistics
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.94+0.02 (+0.25%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Olema Pharmaceuticals by the numbers
Olema Pharmaceuticals has a market capitalization of $694.7 million based on 87.50M shares outstanding. With trailing EPS of $-2.12, Olema Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.0% below its 50-day average and 49.8% below its 200-day average.
Average daily trading volume is 1.07M shares, or about $8.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OLMA valuation vs. peer median
| Metric | OLMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $694.73M | $690.28M | +1% |
| Avg. volume | 1.07M | 838.59K | +27% |
Peer median across 8 companies: WVE, PHAR, COLL, NVCT, ZVRA, AVTX, ABUS, DSGN.
Valuation
- Market cap
- $694.73M
- EPS (TTM)
- $-2.12
- Shares outstanding
- 87.50M
Price and trading
- Previous close
- 7.92
- Open
- 7.90
- Day range
- 7.79 – 8.23
- 52-week range
- 6.65 – 36.26
- 52-week change
- -23.95%
- Beta
- —
- Volume
- 818.55K
- Average volume
- 1.07M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 694.73M
- Forward Pe
- -3.01
- Eps
- -2.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 36.26
- Week52 Low
- 6.65
- Avg Volume
- 1.07M
- Shares Outstanding
- 87.50M
- Ma50
- 10.31
- Ma200
- 15.81
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -78.10%
- Pct From52w Low
- 19.40%